XML 86 R36.htm IDEA: XBRL DOCUMENT v3.22.1
FINANCIAL ASSETS AND LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2021
Financial Assets And Liabilities  
Schedule of financial assets at amortized cost

 

    12.31.2021   12.31.2020
Non-current        
Term deposit   100   100
Other   5   -
Total non-current   105   100
Current        
Public securities (1)   -   25
Other   5   -
Total current   5   25

 

(1)Received in accordance with the mechanism set forth by SE Resolution No. 54/19 for the settlement of receivables under Natural Gas Surplus Injection Promotion Programs.
Schedule of financial assets at fair value through profit and loss

 

    12.31.2021   12.31.2020
Non-current        
Shares   29   11
Total non-current   29   11
         
Current        
Government securities    278   204
Corporate bonds   19   -
Shares   120   29
Investment funds   41   92
Total current   458   325
Schedule of trade and other receivables

 

Note   12.31.2021   12.31.2020
Non-Current          
Related parties 16   23   29
Tax credits     9   5
Prepaid expenses     1   -
Financial credits     -   7
Other     1   2
Other receivables, net     34   43
           
Total non-current     34   43

 

 

  Note   12.31.2021   12.31.2020
Current          
Receivables from MAT     24   15
CAMMESA     89   178
Receivables from oil and gas sales      69   23
Receivables from petrochemistry sales     71   39
Related parties 16   7   4
Other     5   4
Impairment of trade receivables     (9)   (16)
Trade receivables, net     256   247
           
           
Current          
Related parties 16   8   41
Tax credits     5   5
Receivables for complementary activities     2   5
Prepaid expenses     10   4
Financial credit     10   4
Guarantee deposits     30   3
Contractual penalty to collect     -   3
Insurance to recover     1   6
Expenses to be recovered     -   7
Credits for the sale of subsidiary     41   -
Credit for sale of financial instruments     6   -
Argentine Natural Gas Production Promotion Plan     14   -
Other     14   16
Other receivables, net     141   94
           
Total current     397   341

 
Schedule of allowance for the impairment of trade receivables

The movements in the impairment of trade receivables are as follows:

  Note   12.31.2021   12.31.2020   12.31.2019
At the beginning  ###   16   68   34
Impairment (1)     1   63   58
Utilizations     -   (7)   (13)
Reversal of unused amounts     (6)   (3)   (2)
Net foreign currency exchange differences      (2)   (2)   (1)
Gain on monetary position, net     -   (28)   (8)
Reclasification to assets clasified as held for sales     -   (75)   -
At the end of the year     9   16   68

 

(1)It includes US$ 26 million and US$ 23 million corresponding to Discontinued operations for fiscal year 2020 and 2019, respectively. As of December 31, 2020, includes US$ 13 million corresponding to the receivable impairment related to the exchange difference between the price of gas purchased by distributors and the price of gas recognized in distributors´s final tariffs between April 2018 and March 2019 to be assumed by the Federal Government in accordance to PEN Decree No. 1,053/18 (see Note 15).
The movements in the impairment of other financial assets are as follows:

The movements in the impairment of other financial assets are as follows:

  Note   12.31.2021   12.31.2020   12.31.2019
At the beginning  ###   -   6   8
Impairment (1)     -   2   1
Reversal of unused amounts     -   (7)   (2)
Gain on monetary position, net     -   -   (1)
Reclasification to assets clasified as held for sales     -   (1)   -
At the end of the year     -   -   6

 

(1)It includes US$ 1 million and US$ 1 million corresponding to Discontinued operations for fiscal year 2020 and 2019, respectively.
Schedule of cash and cash equivalents

 

    12.31.2021   12.31.2020
Banks   26   70
Investment funds   84   71
Total   110   141
Schedule of borrowings

 

      12.31.2021   12.31.2020
Non-Current          
Financial borrowings     58   75
Corporate bonds     1,301   1,297
Total Non-Current     1,359   1,372
           
Current          
Bank overdrafts     11   37
Financial borrowings     29   88
Corporate bonds     39   117
Total Current     79   242
Total     1,438   1,614

 
Schedule of changes in borrowings

12.5.1 Movements in the borrowings:

  Note   12.31.2021   12.31.2020   12.31.2019
At the beginning of the year     1,614   1,947   2,177
Proceeds from borrowings     188   353   556
Payment of borrowings     (336)   (300)   (550)
Accrued interest     137   176   185
Payment of interests     (140)   (201)   (148)
Net foreign currency exchange difference     (22)   (18)   50
Results for the repurchase of corporate bonds     -   (43)   (27)
Costs capitalized in property, plant and equipment 11.1   -   10   17
Cancellation through dividend compensation     -   (12)   -
Decrease through offsetting  with trade receivables     -   -   (135)
Gain on monetary position, net     -   (43)   (87)
Repurchase and redemption of corporate bonds     (3)   (155)   (91)
Reclassification to liabilities associated to assets classified as held for sale     -   (100)   -
At the end of the year     1,438   1,614   1,947
Schedule of borrowings composition

Type of instrument   Company   Currency   Residual value     Interest   Rate   Expiration   Book value as of 12.31.2021
               
                               
Corporate bonds (1)                              
T Series CB   PAMPA   US$   389     Fixed   7.38%   Jul-23   400
Class 1 CB   PAMPA   US$   636     Fixed   7.50%   Jan-27   648
Class 3 CB   PAMPA   US$   293     Fixed   9.13%   Apr-29   292
                              1,340
Financial loans (2)                              
    PAMPA   US$   23     Variable   Libor + 4.21%   May-24   23
                              23
Other financial loans (3)                              
    PAMPA   US$   22     Variable   Libor + 0.35%   Jul-22   22
    PAMPA   US$   43     Variable   Libor + 0%   Aug-23   42
                              64
Bank overdrafts                              
    PAMPA   $   11     Fixed   33.00%   Jan-22   11
                              11
                              1,438

 

(1)On September 27, 2021, the Company repaid at maturity Class 6 CBs for $ 6,355 million.

As of December 31, 2021, the Company, through its subsidiaries, held in its portfolio US$ 110.4 million face value of its 2023 CBs, US$ 114.0 million face value of its 2027 CBs and US$ 7.5 million face value of its 2029 CBs.

 

(2)During the fiscal year ended December 31, 2021, the Company canceled short-term financing with local financial entities, net of borrowings, for $ 8,158 million. Additionally, the Company repaid at maturity two principal installments for the credit facility sponsored by FINNVERA in the amount of US$ 7.7 million. After the end of the fiscal year, the Company repaid at maturity $ 1,178 million for banking debt taken out with domestic financial entities.

 

(3)During the fiscal year ended December 31, 2021, the Company received disbursements in the amount of US$ 27 million under the credit facilities taken out with BNP in 2020.

 

 

 

Type of instrument   Company   Currency   Residual value     Interest   Rate   Expiration   Book value as of 12.31.2020
               
                               
Corporate bonds(1)                              
Serie 6 CB (2)   PAMPA   $   76     Variable   Badlar + 2.5%   Aug-21   77
T Series CB (3)   PAMPA   US$   389     Fixed   7.38%    Jul-23   399
Class 1 CB (3)   PAMPA   US$   636     Fixed   7.50%   Jan-27   647
Class 3 CB    PAMPA   US$   293     Fixed   9.13%   Apr-29   291
                              1,414
Financial loans(4)                              
    PAMPA   $   18     Fixed   32.50%   Apr-21   19
    PAMPA   $   57     Variable   Badlar + 7%   May-21   61
    PAMPA   US$   31     Variable   Libor + 4.21%   May-24   31
                              111
Other financial operations (5)                          
    PAMPA   US$   2     Variable   Libor   Jul-21   2
    PAMPA   US$   50     Variable   Libor   Aug-23   50
                              52
Bank overdrafts                              
    PAMPA   $   36     Fixed   Between 30% and 34%   Jan-21   37
                              37
                              1,614

 

(1)In the months of July, October and November 2020, the Company paid at maturity Class 4, Class 5 and Series E CBs, the first two issued on April 30, 2020, for a face value of $ 1,238 million, $ 565 million and $ 575 million at a Badlar rate +3%, Badlar rate + 5% and Badlar rate + 0%, respectively.

 

(2)Issued on July 29, 2020.

 

(3)During the fiscal year ended December 31, 2020, the Company and its subsidiaries acquired Series T and Class 1 corporate bonds at their respective market values for a face value of US$ 148 million; therefore, the Company recorded profits for US$ 39 million, which are disclosed in the “Results for the repurchase of corporate bonds” line item under Other financial results. As of December 31, 2020, the Company, through its subsidiaries, held in its portfolio: Series T and Class I CBs for a face value of US$ 35 million and US$ 11 million, respectively.

 

(4)During the fiscal year ended December 31, 2020, the Company took on new financing with domestic financial entities, net of cancellations and early cancellations, for a total $1,600 million, and paid at maturity financing loans in the amount of US$ 92 million.

 

(5)On October 2, 2020, the Company was granted a credit facility for up to US$ 50 million at Libor rate plus 0.0%, which is secured by a Total Return Swap, the underlying asset of which is own CBs held in treasury by the Company for a total amount of US$ 185.9 million. Any disbursement requested by the Company under this agreement should be secured with term deposits held in BNP by the Company, and the owed principal may not exceed 95% of these funds. The cash flow generated by the assigned assets may be destined to: i) the extension of the above-mentioned credit facility; and/or ii) the cancellation of expenses, interest and/or disbursements. It is worth highlighting that BNP is not empowered to dispose of the Total Return Swap’s underlying asset, and may only use it to a limited extent to guarantee certain transactions, but may under no circumstances lose its condition as asset holder. The Company may cancel the agreement at any time, in whole or in part, without incurring any penalty, with no other requirement than the giving of notice by a reliable means or automatically in case any of the events of default stipulated in the agreement is verified. Finally, at the transaction’s maturity date, the counterparty should return to the Company the Total Return Swap’s underlying asset and any associated cash flow. The Company has received disbursements in the amount of US$ 51.5 million under certain credit facilities with BNP.
Schedule of trade and other payables

  Note   12.31.2021   12.31.2020
Non-Current          
Compensation agreements      3   6
Finance lease liability     9   10
Other payables     12   16
Total non-current     12   16
           
           
Current          
Suppliers     154   92
Customer advances     4   2
Related parties 16   15   5
Trade payables     173   99
           
Compensation agreements      2   1
Finance lease liability     4   2
Advances received for sales of subsidiary     -   12
Other     3   2
Other payables     9   17
           
Total current     182   116
Schedule of financial instruments

As of December 31, 2021   Financial assets/liabilities at amortized cost   Financial assets/liabilities at fair value through profit and losss   Subtotal financial assets/liabilities   Non financial assets/liabilities   Total
Assets                    
Trade receivables and other receivables   376   30   406   25   431
Financial assets at amortized cost                    
Term deposit   100   -   100   -   100
Other   10   -   10   -   10
Financial assets at fair value through profit
and loss		                  
Government securities    -   278   278   -   278
Corporate bonds   -   19   19   -   19
Shares   -   149   149   -   149
Investment funds   -   41   41   -   41
Cash and cash equivalents   26   84   110   -   110
Total   512   601   1,113   25   1,138
                     
Liabilities                    
Trade and other liabilities   190   -   190   4   194
Borrowings   1,438   -   1,438   -   1,438
Total   1,628   -   1,628   4   1,632

 

As of December 31, 2020   Financial assets/liabilities at amortized cost   Financial assets/liabilities at fair value through profit and losss   Subtotal financial assets/liabilities   Non financial assets/liabilities   Total
Assets                    
Trade receivables and other receivables   366   3   369   15   384
Financial assets at fair value through profit and loss                    
Term deposit   100   -   100   -   100
Public securities   25   -   25   -   25
Financial assets at fair value through profit and loss                    
Government securities    -   204   204   -   204
Shares   -   40   40   -   40
Investment funds   -   92   92   -   92
Cash and cash equivalents   70   71   141   -   141
Total   561   410   971   15   986
                     
Liabilities                    
Trade and other liabilities   130   -   130   2   132
Borrowings   1,614   -   1,614   -   1,614
Total   1,744   -   1,744   2   1,746
Schedule of income, expenses, gains and losses from financial instruments

The income, expenses, gains and losses derived from each of the financial instrument categories are indicated below:

 

As of December 31, 2021   Financial assets/liabilities at amortized cost   Financial assets/liabilities at fair value through profit and losss   Subtotal financial assets/liabilities    Non Financial assets/ liabilities    Total
Interest income   10   -   10   -   10
Interest expense   (138)   -   (138)   (40)   (178)
Foreign exchange, net   (11)   (19)   (30)   33   3
Results from financial instruments at fair value   -   (15)   (15)   -   (15)
Gains (losses) from present value measurement   2   -   2   (3)   (1)
Other financial results   (4)   -   (4)   (4)   (8)
Total   (141)   (34)   (175)   (14)   (189)
                     
                     
As of December 31, 2020   Financial assets/liabilities at amortized cost   Financial assets/liabilities at fair value through profit and losss   Subtotal financial assets/liabilities    Non Financial assets/ liabilities    Total
Interest income   9   -   9   -   9
Interest expense   (164)   -   (164)   (6)   (170)
Foreign exchange, net   38   (35)   3   11   14
Results from financial instruments at fair value   -   30   30   -   30
Gains (losses) from present value measurement   6   -   6   (4)   2
Other financial results   36   -   36   (5)   31
Total   (75)   (5)   (80)   (4)   (84)
                     
                     
                     
                     
As of December 31, 2019   Financial assets/liabilities at amortized cost   Financial assets/liabilities at fair value through profit and losss   Subtotal financial assets/liabilities    Non Financial assets/ liabilities    Total
Interest income   20   3   23   -   23
Interest expense   (163)   -   (163)   (20)   (183)
Foreign exchange, net   5   (14)   (9)   3   (6)
Results from financial instruments at fair value   -   88   88   -   88
Gains (losses) from present value measurement   55   -   55   -   55
Other financial results   32   -   32   2   34
Total   (51)   77   26   (15)   11
Schedule of fair value of financial instruments

The following table shows the Company’s financial assets and liabilities measured at fair value as of December 31, 2021 and 2020:

 

As of December 31, 2021   Level 1   Level 3   Total
Assets            
Financial assets at fair value through
profit and losss		            
Government securities   278   -   278
Corporate bonds   19   -   19
Investment funds   41   -   41
Shares   120   29   149
Cash and cash equivalents            
Investment funds   84   -   84
Other receivables   30   -   30
Total assets   572   29   601

 

 

As of December 31, 2020   Level 1   Level 2   Level 3   Total
Assets                
Financial assets at fair value through
 profit and losss		                
Government securities   204   -   -   204
Investment funds   92   -   -   92
Shares   29   -   11   40
Cash and cash equivalents                
Investment funds   71   -   -   71
Other receivables   3   -   -   3
Assets classified as held for sale (1)   13   100   -   113
Total assets   412   100   11   523

 

 

(1)Corresponds to the net assets and liabilities held for sale corresponding to divestment in the stake in Edenor.